CUL4A overexpression as an independent adverse prognosticator in intrahepatic cholangiocarcinoma. - Wikidata - wikimedia - TriplyDB

CUL4A overexpression as an independent adverse prognosticator in intrahepatic cholangiocarcinoma.

CUL4A overexpression as an independent adverse prognosticator in intrahepatic cholangiocarcinoma.

http://www.wikidata.org/entity/Q33759631

about

S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway.

P2860

Q47912411-515949AB-7099-461B-9BCC-53F9DFEF91DC

P2860

CUL4A overexpression as an independent adverse prognosticator in intrahepatic cholangiocarcinoma.

http://www.wikidata.org/entity/Q33759631

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

CUL4A overexpression as an ind ...... trahepatic cholangiocarcinoma.

@ast

CUL4A overexpression as an ind ...... trahepatic cholangiocarcinoma.

@en

type

label

CUL4A overexpression as an ind ...... trahepatic cholangiocarcinoma.

@ast

CUL4A overexpression as an ind ...... trahepatic cholangiocarcinoma.

@en

prefLabel

CUL4A overexpression as an ind ...... trahepatic cholangiocarcinoma.

@ast

CUL4A overexpression as an ind ...... trahepatic cholangiocarcinoma.

@en

P1433

Q33759631-B73E6A2F-064F-43C8-A99C-ECB19BA33FF3

P1476

Q33759631-0DF0C614-4187-4391-B282-A5C809E8D4EB

P2093

Q33759631-3CF9C69D-55C0-4378-8C73-707F1DE1DD2F

Q33759631-47775DFD-03E7-4658-BBAF-C8F6521252A8

Q33759631-4C829933-0B19-45AC-86C8-1705B052CE3B

Q33759631-5F3676B5-A6F5-4794-ABEC-1AF3E75040C5

Q33759631-9298CF15-70E2-4832-B20D-55E77FFAB2A0

Q33759631-B3313993-2F56-49AA-9459-3CFCA5992658

Q33759631-C7C79A94-3888-4367-9E7F-E4D746F0B26B

Q33759631-E392E1A2-DBEA-4F51-969E-C5F0476B62D8

P2860

Q33759631-0286A9BE-1037-4EF1-839D-B84F1DA60A48

Q33759631-05D710A4-844C-46BD-9C0F-450D69117E42

Q33759631-08E0CD3C-FED8-4E7E-9C42-798174EEBDFA

Q33759631-0C5517EA-83B2-43E3-B7B0-D460756B00E7

Q33759631-108D5D5A-57CA-4602-86EF-573236D9EEB1

Q33759631-11B11439-C3A6-4A85-A17F-41FBD10B04A5

Q33759631-134FA4A2-776C-4E29-907B-0EDE1FED61BF

Q33759631-1EFA5506-1E4D-43FF-A5EF-A505FE3AC210

Q33759631-2090F754-F43B-47C8-8195-1262B058A769

Q33759631-22B83B1A-96F0-4F1C-9F60-AB7B6E1921A6

P2888

Q33759631-2BCB7C85-1525-43C9-B9A7-65EB8DE508DA

P304

Q33759631-31F45B0F-5256-4F69-A513-2699445127CA

P31

Q33759631-801A84F0-790D-4893-82B8-694BBA8D1171

P356

Q33759631-161F00A1-2166-4755-871C-ACC8CEC7D6F9

P407

Q33759631-E84779CF-EA73-4A5D-8FB8-AF24DE2F1067

P433

Q33759631-BB1A40E7-60E8-4274-AB74-B5EDED1323BE

P478

Q33759631-D7027C6F-A6A5-4C47-AC4A-936DBF7B4FF7

P577

Q33759631-4E39EC8B-D225-4A4E-909F-44B6F809171A

P6179

Q33759631-3BEE546B-B52A-4B91-930B-CC276D273D8B

P698

Q33759631-AC5FF4A4-40E3-4F2A-B7C3-95904BB69AEC

P921

Q33759631-4709782D-7192-4B21-AE54-786C620BE672

Q33759631-B233CD1D-2C51-420C-B725-1043F04245D9

P932

Q33759631-A575683E-52CB-4BBA-8AF1-5E4BCB11331A

P356

S12885-017-3389-Z

P1433

P1476

CUL4A overexpression as an ind ...... trahepatic cholangiocarcinoma.

@en

P2093

Chang-Han Chen

http://www.w3.org/2001/XMLSchema#string

Gong -Kai Huang

http://www.w3.org/2001/XMLSchema#string

Hock-Liew Eng

http://www.w3.org/2001/XMLSchema#string

Huey-Ling You

http://www.w3.org/2001/XMLSchema#string

Shao-Wen Weng

http://www.w3.org/2001/XMLSchema#string

Ting-Ting Liu

http://www.w3.org/2001/XMLSchema#string

Wan-Ting Huang

http://www.w3.org/2001/XMLSchema#string

Yu-Ching Wei

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery

WD40 protein FBW5 promotes ubiquitination of tumor suppressor TSC2 by DDB1-CUL4-ROC1 ligase

Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001

TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas

Involvement of CUL4 ubiquitin E3 ligases in regulating CDK inhibitors Dacapo/p27Kip1 and cyclin E degradation

A novel function of CRL4(Cdt2): regulation of the subunit structure of DNA polymerase δ in response to DNA damage and during the S phase

Cul4A targets p27 for degradation and regulates proliferation, cell cycle exit, and differentiation during erythropoiesis

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

A phase 2 study of bortezomib in relapsed, refractory myeloma.

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.

P2888

s12885-017-3389-z

P304

395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-017-3389-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085751682

http://www.w3.org/2001/XMLSchema#string

P698

28576144

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

5457619

http://www.w3.org/2001/XMLSchema#string